106 related articles for article (PubMed ID: 12950236)
1. CD7 expression by CD34+ cells in CML patients, of prognostic significance?
Normann AP; Egeland T; Madshus IH; Heim S; Tjønnfjord GE
Eur J Haematol; 2003 Oct; 71(4):266-75. PubMed ID: 12950236
[TBL] [Abstract][Full Text] [Related]
2. CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia.
Kosugi N; Ebihara Y; Nakahata T; Saisho H; Asano S; Tojo A
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):505-11. PubMed ID: 15701834
[TBL] [Abstract][Full Text] [Related]
3. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
Martín-Henao GA; Quiroga R; Sureda A; García J
Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
[TBL] [Abstract][Full Text] [Related]
4. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
[TBL] [Abstract][Full Text] [Related]
5. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J
Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720
[TBL] [Abstract][Full Text] [Related]
6. High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia.
Fløisand Y; Normann AP; Heim S; Lund-Johansen F; Tjønnfjord GE
Scand J Clin Lab Invest; 2008; 68(2):93-8. PubMed ID: 17852828
[TBL] [Abstract][Full Text] [Related]
7. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization.
Takahashi N; Miura I; Saitoh K; Miura AB
Blood; 1998 Dec; 92(12):4758-63. PubMed ID: 9845542
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells.
De Fabritiis P; Dowding C; Bungey J; Chase A; Angus G; Szydlo R; Goldman JM
Leuk Lymphoma; 1993 Sep; 11(1-2):51-61. PubMed ID: 7693107
[TBL] [Abstract][Full Text] [Related]
9. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
10. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
11. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia.
Kawaishi K; Kimura A; Katoh O; Sasaki A; Oguma N; Ihara A; Satow Y
Br J Haematol; 1996 May; 93(2):367-74. PubMed ID: 8639430
[TBL] [Abstract][Full Text] [Related]
12. Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.
Thoma SJ; Lamping CP; Ziegler BL
Blood; 1994 Apr; 83(8):2103-14. PubMed ID: 7512840
[TBL] [Abstract][Full Text] [Related]
13. [Expression of beta 2 integrins and L-selectin on CML cells after treatment with IFN-alpha and allo-bone marrow transplantation].
Tong X; Luo S; Hong W
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):474-6. PubMed ID: 11235567
[TBL] [Abstract][Full Text] [Related]
14. Small, abnormal B lymphoid blast populations in chronic myelogenous leukemia at diagnosis: Does this finding indicate an accelerated course?
Soma L; Oehler VG; Ding C; Cherian S
Cytometry B Clin Cytom; 2016 Sep; 90(5):440-8. PubMed ID: 26800237
[TBL] [Abstract][Full Text] [Related]
15. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
[TBL] [Abstract][Full Text] [Related]
16. Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib.
Janssen JJ; Deenik W; Smolders KG; van Kuijk BJ; Pouwels W; Kelder A; Cornelissen JJ; Schuurhuis GJ; Ossenkoppele GJ
Leukemia; 2012 May; 26(5):977-84. PubMed ID: 22157734
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
19. Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.
Rogers SL; Zhao Y; Jiang X; Eaves CJ; Mager DL; Rouhi A
Mol Cancer; 2010 Feb; 9():41. PubMed ID: 20175919
[TBL] [Abstract][Full Text] [Related]
20. Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells.
Li Y; Deng Z; Zho J; Ding B; Shi Y; Li Y
Acta Haematol; 2014; 132(2):172-6. PubMed ID: 24603361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]